nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—DRD5—bipolar disorder	0.303	0.372	CbGaD
L-DOPA—DRD4—bipolar disorder	0.155	0.19	CbGaD
L-DOPA—DRD3—bipolar disorder	0.133	0.164	CbGaD
L-DOPA—DRD1—bipolar disorder	0.131	0.161	CbGaD
L-DOPA—DRD2—bipolar disorder	0.0924	0.113	CbGaD
L-DOPA—DRD3—telencephalic ventricle—bipolar disorder	0.00739	0.133	CbGeAlD
L-DOPA—DDC—telencephalic ventricle—bipolar disorder	0.0072	0.13	CbGeAlD
L-DOPA—DRD1—telencephalic ventricle—bipolar disorder	0.00529	0.0955	CbGeAlD
L-DOPA—DDC—blood plasma—bipolar disorder	0.00343	0.0619	CbGeAlD
L-DOPA—DRD2—telencephalic ventricle—bipolar disorder	0.00313	0.0564	CbGeAlD
L-DOPA—PSIP1—thyroid gland—bipolar disorder	0.00213	0.0384	CbGeAlD
L-DOPA—L-Tryptophan—TPH2—bipolar disorder	0.0021	0.404	CrCbGaD
L-DOPA—PSIP1—nervous system—bipolar disorder	0.00179	0.0323	CbGeAlD
L-DOPA—CYP2D6—urine—bipolar disorder	0.00172	0.031	CbGeAlD
L-DOPA—PSIP1—cerebellum—bipolar disorder	0.00169	0.0304	CbGeAlD
L-DOPA—SLC7A8—thyroid gland—bipolar disorder	0.0014	0.0253	CbGeAlD
L-DOPA—PSIP1—brain—bipolar disorder	0.00137	0.0247	CbGeAlD
L-DOPA—SLC7A8—nervous system—bipolar disorder	0.00118	0.0213	CbGeAlD
L-DOPA—DRD4—brain—bipolar disorder	0.00114	0.0206	CbGeAlD
L-DOPA—SLC7A8—cerebellum—bipolar disorder	0.00111	0.02	CbGeAlD
L-DOPA—SLC7A5—thyroid gland—bipolar disorder	0.00109	0.0196	CbGeAlD
L-DOPA—DRD3—nervous system—bipolar disorder	0.00105	0.0189	CbGeAlD
L-DOPA—DDC—nervous system—bipolar disorder	0.00102	0.0184	CbGeAlD
L-DOPA—DRD5—nervous system—bipolar disorder	0.000982	0.0177	CbGeAlD
L-DOPA—SLC7A5—nervous system—bipolar disorder	0.000915	0.0165	CbGeAlD
L-DOPA—SLC7A8—brain—bipolar disorder	0.000902	0.0163	CbGeAlD
L-DOPA—CYP2D6—blood plasma—bipolar disorder	0.000896	0.0162	CbGeAlD
L-DOPA—SLC7A5—cerebellum—bipolar disorder	0.000861	0.0155	CbGeAlD
L-DOPA—SLC16A10—thyroid gland—bipolar disorder	0.000833	0.015	CbGeAlD
L-DOPA—DRD3—brain—bipolar disorder	0.000801	0.0144	CbGeAlD
L-DOPA—DDC—brain—bipolar disorder	0.00078	0.0141	CbGeAlD
L-DOPA—DRD5—brain—bipolar disorder	0.000751	0.0135	CbGeAlD
L-DOPA—DRD1—nervous system—bipolar disorder	0.00075	0.0135	CbGeAlD
L-DOPA—SLC7A5—brain—bipolar disorder	0.000699	0.0126	CbGeAlD
L-DOPA—SLC16A10—cerebellum—bipolar disorder	0.000659	0.0119	CbGeAlD
L-DOPA—Methyldopa—COMT—bipolar disorder	0.000617	0.119	CrCbGaD
L-DOPA—DRD1—brain—bipolar disorder	0.000573	0.0103	CbGeAlD
L-DOPA—Dopamine—DRD5—bipolar disorder	0.000477	0.0918	CrCbGaD
L-DOPA—DRD2—nervous system—bipolar disorder	0.000443	0.008	CbGeAlD
L-DOPA—DRD2—cerebellum—bipolar disorder	0.000417	0.00752	CbGeAlD
L-DOPA—DRD2—brain—bipolar disorder	0.000339	0.00611	CbGeAlD
L-DOPA—Dopamine—COMT—bipolar disorder	0.000301	0.058	CrCbGaD
L-DOPA—CYP2D6—nervous system—bipolar disorder	0.000266	0.0048	CbGeAlD
L-DOPA—CYP2D6—cerebellum—bipolar disorder	0.000251	0.00452	CbGeAlD
L-DOPA—Dopamine—DRD4—bipolar disorder	0.000244	0.047	CrCbGaD
L-DOPA—Dopamine—MAOA—bipolar disorder	0.000227	0.0437	CrCbGaD
L-DOPA—Dopamine—DRD3—bipolar disorder	0.00021	0.0405	CrCbGaD
L-DOPA—Dopamine—DRD1—bipolar disorder	0.000207	0.0398	CrCbGaD
L-DOPA—CYP2D6—brain—bipolar disorder	0.000204	0.00367	CbGeAlD
L-DOPA—Dopamine—SLC6A3—bipolar disorder	0.000196	0.0377	CrCbGaD
L-DOPA—Dopamine—HTR1A—bipolar disorder	0.000172	0.033	CrCbGaD
L-DOPA—Norepinephrine—DRD2—bipolar disorder	0.000157	0.0301	CrCbGaD
L-DOPA—Dopamine—SLC6A4—bipolar disorder	0.000146	0.0282	CrCbGaD
L-DOPA—Dopamine—DRD2—bipolar disorder	0.000146	0.028	CrCbGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	2.8e-05	0.000224	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—TSHB—bipolar disorder	2.8e-05	0.000224	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—PDE4B—bipolar disorder	2.8e-05	0.000224	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—TACR1—bipolar disorder	2.8e-05	0.000224	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—AKR1C4—bipolar disorder	2.79e-05	0.000223	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—DRD1—bipolar disorder	2.77e-05	0.000222	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HTR2C—bipolar disorder	2.77e-05	0.000222	CbGpPWpGaD
L-DOPA—DDC—Metabolism—ADCY2—bipolar disorder	2.72e-05	0.000217	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TRPC3—bipolar disorder	2.71e-05	0.000217	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—HTR2A—bipolar disorder	2.71e-05	0.000217	CbGpPWpGaD
L-DOPA—DRD2—G alpha (i) signalling events—POMC—bipolar disorder	2.7e-05	0.000216	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	2.69e-05	0.000215	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—DRD3—bipolar disorder	2.69e-05	0.000215	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—IMPA2—bipolar disorder	2.68e-05	0.000214	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—HTR2A—bipolar disorder	2.67e-05	0.000214	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—DRD5—bipolar disorder	2.64e-05	0.000211	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR1A—bipolar disorder	2.61e-05	0.000209	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—DGKH—bipolar disorder	2.6e-05	0.000208	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—RGS4—bipolar disorder	2.59e-05	0.000207	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ADM—bipolar disorder	2.59e-05	0.000207	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR1A—bipolar disorder	2.59e-05	0.000207	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—TAC1—bipolar disorder	2.57e-05	0.000205	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—DGKH—bipolar disorder	2.57e-05	0.000205	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR1A—bipolar disorder	2.55e-05	0.000204	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—TAC1—bipolar disorder	2.55e-05	0.000204	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—TRPC3—bipolar disorder	2.54e-05	0.000203	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TSHB—bipolar disorder	2.52e-05	0.000202	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PDE4B—bipolar disorder	2.52e-05	0.000202	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TACR1—bipolar disorder	2.52e-05	0.000202	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR2C—bipolar disorder	2.52e-05	0.000201	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—DRD1—bipolar disorder	2.52e-05	0.000201	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—TAC1—bipolar disorder	2.51e-05	0.000201	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR2C—bipolar disorder	2.5e-05	0.0002	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—DRD1—bipolar disorder	2.46e-05	0.000197	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR2C—bipolar disorder	2.46e-05	0.000197	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—ADCY2—bipolar disorder	2.45e-05	0.000196	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—DRD3—bipolar disorder	2.44e-05	0.000195	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—DRD2—bipolar disorder	2.43e-05	0.000194	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—ADM—bipolar disorder	2.42e-05	0.000194	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—DRD3—bipolar disorder	2.42e-05	0.000193	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—POMC—bipolar disorder	2.4e-05	0.000192	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—DRD5—bipolar disorder	2.38e-05	0.00019	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—TSHB—bipolar disorder	2.36e-05	0.000189	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—TACR1—bipolar disorder	2.36e-05	0.000189	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—PDE4B—bipolar disorder	2.36e-05	0.000189	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR1A—bipolar disorder	2.35e-05	0.000188	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—DRD4—bipolar disorder	2.35e-05	0.000188	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—DRD5—bipolar disorder	2.35e-05	0.000188	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—RGS4—bipolar disorder	2.33e-05	0.000187	CbGpPWpGaD
L-DOPA—DDC—Metabolism—COMT—bipolar disorder	2.33e-05	0.000186	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR1A—bipolar disorder	2.32e-05	0.000185	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—DRD4—bipolar disorder	2.32e-05	0.000185	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—TAC1—bipolar disorder	2.31e-05	0.000185	CbGpPWpGaD
L-DOPA—DDC—Metabolism—MAOA—bipolar disorder	2.31e-05	0.000185	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—HTR2A—bipolar disorder	2.31e-05	0.000184	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—TRPC3—bipolar disorder	2.3e-05	0.000184	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—RGS4—bipolar disorder	2.3e-05	0.000184	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—TAC1—bipolar disorder	2.28e-05	0.000182	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR2C—bipolar disorder	2.27e-05	0.000181	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—DRD1—bipolar disorder	2.24e-05	0.000179	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR2C—bipolar disorder	2.24e-05	0.000179	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—ADCY2—bipolar disorder	2.23e-05	0.000178	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—ADCY2—bipolar disorder	2.21e-05	0.000177	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—DRD2—bipolar disorder	2.21e-05	0.000176	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—ADM—bipolar disorder	2.2e-05	0.000176	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—DRD3—bipolar disorder	2.2e-05	0.000176	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—DRD2—bipolar disorder	2.19e-05	0.000175	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—ADCY2—bipolar disorder	2.18e-05	0.000174	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—POMC—bipolar disorder	2.16e-05	0.000173	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—DRD2—bipolar disorder	2.16e-05	0.000173	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	2.15e-05	0.000172	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—TSHB—bipolar disorder	2.14e-05	0.000171	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PDE4B—bipolar disorder	2.14e-05	0.000171	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—TACR1—bipolar disorder	2.14e-05	0.000171	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—POMC—bipolar disorder	2.14e-05	0.000171	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—AKR1C4—bipolar disorder	2.13e-05	0.000171	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—DRD4—bipolar disorder	2.13e-05	0.000171	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—DRD4—bipolar disorder	2.1e-05	0.000168	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HTR2A—bipolar disorder	2.09e-05	0.000167	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR1A—bipolar disorder	2.09e-05	0.000167	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TAC1—bipolar disorder	2.06e-05	0.000164	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—HTR2A—bipolar disorder	2.05e-05	0.000164	CbGpPWpGaD
L-DOPA—CYP2D6—Biological oxidations—POMC—bipolar disorder	2.02e-05	0.000162	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR2C—bipolar disorder	2.02e-05	0.000161	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—DRD1—bipolar disorder	2.02e-05	0.000161	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—ADCY2—bipolar disorder	2.01e-05	0.000161	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TRPC3—bipolar disorder	2e-05	0.00016	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—DRD2—bipolar disorder	1.99e-05	0.000159	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—ADCY2—bipolar disorder	1.98e-05	0.000158	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—DGKH—bipolar disorder	1.96e-05	0.000157	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NTRK2—bipolar disorder	1.96e-05	0.000157	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—DRD2—bipolar disorder	1.96e-05	0.000157	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—DRD3—bipolar disorder	1.95e-05	0.000156	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR1A—bipolar disorder	1.95e-05	0.000156	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—GSK3A—bipolar disorder	1.94e-05	0.000155	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—TAC1—bipolar disorder	1.92e-05	0.000154	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ADM—bipolar disorder	1.91e-05	0.000153	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—DRD4—bipolar disorder	1.9e-05	0.000152	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—DRD1—bipolar disorder	1.89e-05	0.000151	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR2C—bipolar disorder	1.89e-05	0.000151	CbGpPWpGaD
L-DOPA—DDC—Metabolism—MTHFR—bipolar disorder	1.88e-05	0.00015	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TSHB—bipolar disorder	1.86e-05	0.000149	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PDE4B—bipolar disorder	1.86e-05	0.000149	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TACR1—bipolar disorder	1.86e-05	0.000149	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—POMC—bipolar disorder	1.84e-05	0.000147	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—DRD3—bipolar disorder	1.83e-05	0.000146	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—IMPA1—bipolar disorder	1.81e-05	0.000145	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TRPC3—bipolar disorder	1.8e-05	0.000144	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—DRD5—bipolar disorder	1.8e-05	0.000144	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ADCY2—bipolar disorder	1.78e-05	0.000143	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TRPC3—bipolar disorder	1.78e-05	0.000142	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TCF7L2—bipolar disorder	1.78e-05	0.000142	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR1A—bipolar disorder	1.77e-05	0.000142	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—DRD4—bipolar disorder	1.77e-05	0.000142	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—DRD2—bipolar disorder	1.77e-05	0.000141	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—RGS4—bipolar disorder	1.76e-05	0.000141	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—TAC1—bipolar disorder	1.75e-05	0.00014	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ADM—bipolar disorder	1.72e-05	0.000138	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—DRD1—bipolar disorder	1.71e-05	0.000137	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR2C—bipolar disorder	1.71e-05	0.000137	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HTR2A—bipolar disorder	1.7e-05	0.000136	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ADM—bipolar disorder	1.7e-05	0.000136	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TSHB—bipolar disorder	1.68e-05	0.000134	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PDE4B—bipolar disorder	1.68e-05	0.000134	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TACR1—bipolar disorder	1.68e-05	0.000134	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—POMC—bipolar disorder	1.67e-05	0.000134	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—ADCY2—bipolar disorder	1.67e-05	0.000133	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—DRD3—bipolar disorder	1.66e-05	0.000133	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TSHB—bipolar disorder	1.65e-05	0.000132	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PDE4B—bipolar disorder	1.65e-05	0.000132	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TACR1—bipolar disorder	1.65e-05	0.000132	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—POMC—bipolar disorder	1.63e-05	0.000131	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—DRD4—bipolar disorder	1.61e-05	0.000129	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NTRK1—bipolar disorder	1.6e-05	0.000128	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—S100B—bipolar disorder	1.55e-05	0.000124	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR2A—bipolar disorder	1.55e-05	0.000124	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR1A—bipolar disorder	1.54e-05	0.000123	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NDUFV2—bipolar disorder	1.54e-05	0.000123	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR2A—bipolar disorder	1.53e-05	0.000123	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TAC1—bipolar disorder	1.52e-05	0.000121	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—ADCY2—bipolar disorder	1.52e-05	0.000121	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR2A—bipolar disorder	1.51e-05	0.000121	CbGpPWpGaD
L-DOPA—DDC—Metabolism—POMC—bipolar disorder	1.5e-05	0.00012	CbGpPWpGaD
L-DOPA—DDC—Metabolism—INS—bipolar disorder	1.49e-05	0.00012	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—AKR1C4—bipolar disorder	1.49e-05	0.000119	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—DRD1—bipolar disorder	1.49e-05	0.000119	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR2C—bipolar disorder	1.49e-05	0.000119	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NTRK2—bipolar disorder	1.45e-05	0.000116	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—DRD3—bipolar disorder	1.44e-05	0.000115	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—GSK3A—bipolar disorder	1.43e-05	0.000115	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR2A—bipolar disorder	1.39e-05	0.000111	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR1A—bipolar disorder	1.39e-05	0.000111	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR2A—bipolar disorder	1.37e-05	0.00011	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NRG1—bipolar disorder	1.37e-05	0.00011	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR1A—bipolar disorder	1.37e-05	0.000109	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TAC1—bipolar disorder	1.37e-05	0.000109	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TRPC3—bipolar disorder	1.36e-05	0.000109	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—POMC—bipolar disorder	1.36e-05	0.000109	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TAC1—bipolar disorder	1.35e-05	0.000108	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR2C—bipolar disorder	1.34e-05	0.000107	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NR1D1—bipolar disorder	1.34e-05	0.000107	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR2C—bipolar disorder	1.32e-05	0.000106	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—DRD1—bipolar disorder	1.32e-05	0.000106	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ADCY2—bipolar disorder	1.32e-05	0.000105	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TCF7L2—bipolar disorder	1.31e-05	0.000105	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—DRD2—bipolar disorder	1.3e-05	0.000104	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NTRK2—bipolar disorder	1.3e-05	0.000104	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ADM—bipolar disorder	1.3e-05	0.000104	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—DRD3—bipolar disorder	1.3e-05	0.000104	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—GSK3A—bipolar disorder	1.29e-05	0.000103	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NTRK2—bipolar disorder	1.29e-05	0.000103	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NCAN—bipolar disorder	1.28e-05	0.000102	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—GSK3A—bipolar disorder	1.27e-05	0.000102	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PDE4B—bipolar disorder	1.27e-05	0.000101	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TSHB—bipolar disorder	1.27e-05	0.000101	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TACR1—bipolar disorder	1.27e-05	0.000101	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—DRD4—bipolar disorder	1.26e-05	0.000101	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—SLC5A3—bipolar disorder	1.25e-05	0.0001	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—DRD4—bipolar disorder	1.24e-05	9.94e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR2A—bipolar disorder	1.24e-05	9.89e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—POMC—bipolar disorder	1.23e-05	9.87e-05	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—POMC—bipolar disorder	1.22e-05	9.78e-05	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—POMC—bipolar disorder	1.21e-05	9.65e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ADCY2—bipolar disorder	1.19e-05	9.48e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TCF7L2—bipolar disorder	1.18e-05	9.45e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NTRK1—bipolar disorder	1.18e-05	9.44e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—DRD2—bipolar disorder	1.17e-05	9.38e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ADCY2—bipolar disorder	1.17e-05	9.36e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TCF7L2—bipolar disorder	1.17e-05	9.32e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—DRD2—bipolar disorder	1.16e-05	9.26e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR2A—bipolar disorder	1.16e-05	9.25e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—S100B—bipolar disorder	1.15e-05	9.17e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—POMC—bipolar disorder	1.11e-05	8.89e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—POMC—bipolar disorder	1.1e-05	8.77e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NTRK1—bipolar disorder	1.06e-05	8.5e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR2A—bipolar disorder	1.05e-05	8.4e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NTRK1—bipolar disorder	1.05e-05	8.38e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR1A—bipolar disorder	1.05e-05	8.38e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—S100B—bipolar disorder	1.03e-05	8.26e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TAC1—bipolar disorder	1.03e-05	8.25e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—S100B—bipolar disorder	1.02e-05	8.15e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NRG1—bipolar disorder	1.01e-05	8.1e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR2C—bipolar disorder	1.01e-05	8.09e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—DRD1—bipolar disorder	1.01e-05	8.09e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—GSK3B—bipolar disorder	9.96e-06	7.96e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—POMC—bipolar disorder	9.88e-06	7.9e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NTRK2—bipolar disorder	9.84e-06	7.87e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—INS—bipolar disorder	9.82e-06	7.86e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—DRD3—bipolar disorder	9.79e-06	7.83e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GSK3A—bipolar disorder	9.75e-06	7.8e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—DRD4—bipolar disorder	9.51e-06	7.61e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—POMC—bipolar disorder	9.24e-06	7.39e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR2A—bipolar disorder	9.13e-06	7.3e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NRG1—bipolar disorder	9.11e-06	7.29e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CLOCK—bipolar disorder	9.06e-06	7.24e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NRG1—bipolar disorder	8.99e-06	7.19e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ADCY2—bipolar disorder	8.95e-06	7.16e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	8.92e-06	7.13e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—TPH2—bipolar disorder	8.82e-06	7.06e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—TSHB—bipolar disorder	8.82e-06	7.06e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CACNB2—bipolar disorder	8.82e-06	7.06e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—DPYD—bipolar disorder	8.68e-06	6.94e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—POMC—bipolar disorder	8.39e-06	6.71e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR2A—bipolar disorder	8.22e-06	6.57e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR2A—bipolar disorder	8.11e-06	6.48e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CACNA1C—bipolar disorder	8.07e-06	6.46e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NTRK1—bipolar disorder	8.02e-06	6.41e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	7.87e-06	6.29e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—S100B—bipolar disorder	7.8e-06	6.24e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—GSK3B—bipolar disorder	7.35e-06	5.88e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—POMC—bipolar disorder	7.29e-06	5.83e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—INS—bipolar disorder	7.25e-06	5.8e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—SNAP25—bipolar disorder	7.05e-06	5.64e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NRG1—bipolar disorder	6.88e-06	5.5e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—GSK3B—bipolar disorder	6.62e-06	5.29e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—POMC—bipolar disorder	6.56e-06	5.25e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—GSK3B—bipolar disorder	6.53e-06	5.22e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—INS—bipolar disorder	6.53e-06	5.22e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—POMC—bipolar disorder	6.47e-06	5.18e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—INS—bipolar disorder	6.44e-06	5.15e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ADCY2—bipolar disorder	6.24e-06	4.99e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR2A—bipolar disorder	6.2e-06	4.96e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—COMT—bipolar disorder	5.35e-06	4.28e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MAOA—bipolar disorder	5.31e-06	4.25e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GSK3B—bipolar disorder	4.99e-06	4e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—POMC—bipolar disorder	4.95e-06	3.96e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—INS—bipolar disorder	4.93e-06	3.94e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MTHFR—bipolar disorder	4.32e-06	3.46e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—POMC—bipolar disorder	3.46e-06	2.76e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—INS—bipolar disorder	3.44e-06	2.75e-05	CbGpPWpGaD
